GGrantIndex
← Search

Purchase of Pharmaceutical Agents for NIAID Clinical Trials

$777,180Y01FY2020AINIH

National Institute Of Allergy And Infectious Diseases

Investigators

Abstract

DLA Prime Vendor Program, is an intra-agency agreement that allows DAIT/ NIAID to purchase pharmaceutical agents with streamlined government pricing and negotiations.

View original record on NIH RePORTER →